The Role of Interactive Graphics in Drug and Vaccine Design

#virtual #imaging #virus
Share

Thomas Ferrin of UCSF will describe 3D imaging of the Corona virus.  He will be bringing virtual reality imaging equipment for demonstration and for use by the audience.

Interactive computer graphics has been used for more than 60 years to visualize and analyze 3-D molecular structures such as DNA and proteins, and has contributed to the development of many drugs and, more recently, vaccines that are in common use today. Today, VR headsets enable structural biologists to immerse themselves within these molecules in order to gain a better understanding of how they function. This talk will recount the evolution of interactive molecular graphics from the early days of calligraphic CRT displays to the current use of VR headsets such as the one shown here.

The video shows structures from the following article where more details can be found.

"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"

 



  Date and Time

  Location

  Hosts

  Registration



  • Date: 05 Jun 2024
  • Time: 11:00 AM to 02:00 PM
  • All times are (UTC-07:00) Pacific Time (US & Canada)
  • Add_To_Calendar_icon Add Event to Calendar
  • Beeb's Sports Bar and Grill
  • 915 Clubhouse Drive
  • Livermore, California
  • United States 94551
  • Building: golf course restaurant

  • Contact Event Host
  • Group Chair Maureen Vavra  mwvavra@outlook.com

  • Starts 08 May 2024 01:00 AM
  • Ends 05 June 2024 12:00 PM
  • All times are (UTC-07:00) Pacific Time (US & Canada)
  • Admission fee ?






Agenda

Presentation and lunch included with the registration fee.  Depending on the number of registrants the meal will be either a buffet or individual  orders from the menu.   Virtual reality headset will be available for demonstration.



The UCSF Molecular Graphics Lab does Interactive 3D analysis of molecules and cells in virtual reality.

The presentation uses the free ChimeraX virtual reality software developed University of California at San Francisco.